Document:

<PAGE>
                                                                    EXHIBIT 10.1

                               TENTH AMENDMENT TO
                         NON-QUALIFIED STOCK OPTION PLAN
                       FOR EMPLOYEES OF ACQUIRED COMPANIES

         THIS TENTH AMENDMENT (the "Tenth Amendment") is made effective as of
the 30th day of July, 2002, by PER-SE TECHNOLOGIES, INC., a Delaware corporation
(the "Company").

                              W I T N E S S E T H:

         WHEREAS, the Company has previously adopted the Per-Se Technologies,
Inc. Non-Qualified Stock Option Plan for Employees of Acquired Companies, as
amended (the "Plan"); and

         WHEREAS, the Compensation Committee of the Board of Directors of the
Company has duly authorized an amendment of the Plan to decrease the number of
shares available for grant pursuant to the Plan from 1,221,403 shares to
1,157,972 shares, which is a decrease of 63,431 shares.

         NOW, THEREFORE, Section 3 of the Plan is hereby amended by deleting
Section 3 of the Plan in its entirety and replacing it with the following:

                                    SECTION 3

                         SHARES RESERVED UNDER THE PLAN

         "There shall be 1,157,972 shares of Stock reserved for issuance under
         this Plan, and such shares of Stock shall be reserved to the extent
         that the Company deems appropriate from authorized but unissued shares
         of Stock and from shares of Stock which have been repurchased by the
         Company. Furthermore, any shares of Stock subject to an Option that
         remain unissued after the cancellation or expiration of such Option
         thereafter shall again become available for use under this Plan."

         FURTHER, except as specifically amended by this Tenth Amendment, the
Plan shall remain in full force and effect as prior to this Tenth Amendment.

         IN WITNESS WHEREOF, the Company has caused this Tenth Amendment to be
executed on the day and year first above written.

                                      PER-SE TECHNOLOGIES, INC.

                                      By: /s/ PHILIP M. PEAD
                                          ---------------------------------
                                          Philip M. Pead
                                          President and Chief Executive Officer

ATTEST:

By: /s/ PAUL J. QUINER
   ---------------------------------
   Paul J. Quiner
   Corporate Secretary

                                       23<PAGE>
                                                                    EXHIBIT 10.2

                               NINTH AMENDMENT TO
                         NON-QUALIFIED STOCK OPTION PLAN
                           FOR NON-EXECUTIVE EMPLOYEES

         THIS NINTH AMENDMENT (the "Ninth Amendment") is made effective as of
the 30th day of July, 2002, by PER-SE TECHNOLOGIES, INC., a Delaware corporation
(the "Company").

                              W I T N E S S E T H:

         WHEREAS, the Company has previously adopted the Per-Se Technologies,
Inc. Non-Qualified Stock Option Plan for Non-Executive Employees, as amended
(the "Plan"); and

         WHEREAS, the Compensation Committee of the Board of Directors of the
Company has duly authorized an amendment of the Plan to increase the number of
shares available for grant pursuant to the Plan from 3,316,930 shares to
3,980,361 shares, which is an increase of 663,431 shares.

         NOW, THEREFORE, Section 3 of the Plan is hereby amended by deleting
Section 3 of the Plan in its entirety and replacing it with the following:

                                   SECTION 3.

                         SHARES RESERVED UNDER THE PLAN

                           "There shall be 3,980,361 shares of Stock reserved
                  for issuance under this Plan, and such shares of Stock shall
                  be reserved to the extent that the Company deems appropriate
                  from authorized but unissued shares of Stock and from shares
                  of Stock which have been repurchased by the Company.
                  Furthermore, any shares of Stock subject to an Option that
                  remain unissued after the cancellation or expiration of such
                  Option thereafter shall again become available for use under
                  this Plan."

         FURTHER, except as specifically amended by this Ninth Amendment, the
Plan shall remain in full force and effect as prior to this Ninth Amendment.

         IN WITNESS WHEREOF, the Company has caused this Ninth Amendment to be
effective as of the day and year first above written.

                                           PER-SE TECHNOLOGIES, INC.

                                       By: /s/ PHILIP M. PEAD
                                           ---------------------------------
                                           Philip M. Pead
                                           President and Chief Executive Officer

ATTEST:

By: /s/ PAUL J. QUINER
   ---------------------------------
   Paul J. Quiner
   Corporate Secretary

                                       24<PAGE>

                                                                    EXHIBIT 10.3
                               FIRST AMENDMENT TO
                            PER-SE TECHNOLOGIES, INC.
                            DEFERRED STOCK UNIT PLAN

         THIS FIRST AMENDMENT ("First Amendment") to the Per-Se Technologies,
Inc. Deferred Stock Unit Plan (the "Deferred Stock Unit Plan") is made and
executed this 30th day of July, 2002, to be effective as of June 3, 2002.

         WHEREAS, Per-Se Technologies, Inc., a Delaware corporation (the
"Company"), has previously adopted the Deferred Stock Unit Plan; and

         WHEREAS, the Compensation Committee of the Board of Directors of the
Company (the "Committee") has duly authorized an amendment of the Deferred Stock
Unit Plan to provide that the accounts maintained for non-employee Director
participants in the Deferred Stock Unit Plan will be credited on a quarterly
basis as of the first business day of each month in which meeting fees and
retainer amounts would otherwise be payable, consistent with the Company's past
practice in administering accounts under the Non-Employee Director Deferred
Stock Credit Plan formerly maintained by the Company.

         NOW, THEREFORE, pursuant to a resolution of the Committee adopted July
30, 2002, in accordance with Section 7.01 of the Deferred Stock Unit Plan, the
Deferred Stock Unit Plan is hereby amended as follows:

         1. CREDITING ACCOUNTS. The first sentence of Section 4.01 of the
Deferred Stock Unit Plan is hereby deleted in its entirety and replaced by the
following:

         "All Deferred Amounts and Enhancement Bonus shall be converted to Stock
Units and credited to Participants' Accounts on (i) the date that the Deferred
Amounts are deducted through payroll withholding, in the case of employee
Participants, or (ii) the first business day of each month in which the
Participant's Compensation is otherwise payable, in the case of Non-Employee
Director Participants."

         2. EFFECT OF AMENDMENT. Except as specifically amended by this First
Amendment, the Deferred Stock Unit Plan shall remain in full force and effect as
prior to this First Amendment.

         IN WITNESS WHEREOF, the Company has caused this First Amendment to be
duly executed as of the date first above written.

ATTEST:                               PER-SE TECHNOLOGIES, INC.

By: /s/ PAUL J. QUINER                By: /s/ PHILIP M. PEAD
   -------------------------              --------------------------------------
   Paul J. Quiner                         Philip M. Pead
   Corporate Secretary                    President and Chief Executive Officer

                                       25<PAGE>
                                                                    Exhibit 10.1

                             PEDIATRIX MEDICAL GROUP

                      AMENDED AND RESTATED CREDIT AGREEMENT

                      Originally Dated as of June 27, 1996
                 As Amended and Restated as of November 1, 2000
                  As Amended and Restated as of August 14, 2001
                        As Amended as of August 29, 2001

                                 AMENDMENT NO. 2

                            Dated as of June 28, 2002

                      FLEET NATIONAL BANK, AGENT AND LENDER
          U.S. BANK NATIONAL ASSOCIATION, SYNDICATION AGENT AND LENDER
                  HSBC BANK USA, DOCUMENTATION AGENT AND LENDER
                        FLEET SECURITIES, INC., ARRANGER

<PAGE>

                              AMENDMENT NUMBER 2 TO
                      AMENDED AND RESTATED CREDIT AGREEMENT

                            Dated as of June 28, 2002

         This agreement, dated as of June 28, 2002 (this "AMENDMENT"), is among
Pediatrix Medical Group, Inc., a Florida corporation, the Material Related
Entities of Pediatrix Medical Group, Inc. from time to time party hereto, and
the Lenders from time to time party hereto including Fleet National Bank,
formerly known as The First National Bank of Boston, both in its capacity as a
Lender and in its capacity as an Agent, U.S. Bank National Association, formerly
known as Firstar Bank N.A., both in its capacity as a Lender and in its capacity
as Syndication Agent, and HSBC Bank USA, both in its capacity as a Lender and in
its capacity as Documentation Agent. The parties agree as follows:

         1. CREDIT AGREEMENT; DEFINITIONS.

                  1.1. CREDIT AGREEMENT. This Amendment amends the Credit
         Agreement originally dated as of June 27, 1996, as amended and restated
         as of November 1, 2000, as further amended and restated as of August
         14, 2001 and as amended as of August 29, 2001 among the parties hereto
         (as in effect prior to giving effect to this Amendment, the "CREDIT
         AGREEMENT").

                  1.2. DEFINITIONS. Terms used in this Amendment but not defined
         herein are used as defined in the Credit Agreement.

         2. AMENDMENTS. Effective upon the date all the conditions set forth in
Section 4 hereof are satisfied, which conditions must be satisfied no later than
the date provided therein, the Credit Agreement is amended as follows:

                  2.1. SECTION 6.10. Section 6.10 of the Credit Agreement is
         hereby amended to read in its entirety as follows:

                  "6.10. DISTRIBUTIONS. None of the Borrowers shall make any
         Distribution except the following: (i) Distributions in respect of the
         redemption of capital stock of the Company from employees of any
         Borrower; PROVIDED, HOWEVER, that the amount of all such Distributions
         shall not exceed $500,000 in the aggregate in any fiscal year; (ii)
         other Distributions in respect of the redemption of capital stock of
         the Company; PROVIDED, HOWEVER, that the amount of all such
         Distributions shall not exceed $50,000,000 in the aggregate during the
         lifetime of this agreement; (iii) Distributions to the Company by its
         Subsidiaries; (iv) regularly scheduled payments of interest to the
         holders of the Subordinated Notes in accordance with the terms of such
         Subordinated Notes; and (v) regularly scheduled payments of interest to
         the holders of Approved Subordinated Debt or Approved Contingent Debt
         in accordance with the terms of such Approved Subordinated Debt or
         Approved Contingent Debt."

                                     - 1 -
<PAGE>

         3. REPRESENTATION AND WARRANTY. In order to induce the Agent and the
Lenders to enter into this Amendment, each of the Obligors jointly and severally
represents and warrants that, after giving effect to this Amendment, no Default
exists.

         4. CONDITIONS. The effectiveness of this Amendment shall be subject to
the satisfaction of the following condition, which condition must be satisfied
no later than July 3, 2002 or this Amendment shall terminate:

                  4.1. PAYMENT OF FEES AND EXPENSES. The Company shall have paid
         to the Agent (a) for the account of the Lenders the fee as agreed
         between the Borrowers and the Lenders and (b) the reasonable legal fees
         and expenses of the Agent with respect to this Amendment and the
         transactions contemplated hereby.

         5. MISCELLANEOUS. The Credit Agreement as amended by this Amendment
(the "AMENDED CREDIT AGREEMENT") and all of the Credit Documents are each
confirmed as being in full force and effect. This Amendment, the Amended Credit
Agreement and the other Credit Documents referred to herein or therein
constitute the entire understanding of the parties with respect to the subject
matter hereof and thereof and supersede all prior and current understandings and
agreements, whether written or oral. Each of this Amendment and the Amended
Credit Agreement is a Credit Document and may be executed in any number of
counterparts, which together shall constitute one instrument, and shall bind and
inure to the benefit of the parties and their respective successors and assigns,
including as such successors and assigns all holders of any Credit Obligation.
This Amendment shall be governed by and construed in accordance with the laws
(other than the conflict of law rules) of The Commonwealth of Massachusetts.

             [THE REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK.]

                                     - 2 -
<PAGE>
         IN WITNESS WHEREOF, each of the undersigned has duly executed this
Amendment (or caused this Amendment to be executed on its behalf by its officer
or representative thereunto duly authorized) under seal as of the date first
written above.

                             PEDIATRIX MEDICAL GROUP, INC. (Florida)

                             By: /s/ Karl B. Wagner
                                 ----------------------------------------
                                 Karl B. Wagner, Chief Financial Officer

                             ALASKA NEONATOLOGY ASSOCIATES, INC.
                             AUGUSTA NEONATOLOGY ASSOCIATES, P.C.
                             DES MOINES PERINATAL CENTER, P.C.
                             FOOTHILL MEDICAL GROUP, INC.
                             FORT WORTH NEONATAL ASSOCIATES, P.A.
                             OBSTETRIX MEDICAL GROUP OF CALIFORNIA,
                              A PROFESSIONAL CORPORATION
                             MAGELLA HEALTHCARE GROUP, L.P.
                             MAGELLA MEDICAL ASSOCIATES, P.A.
                             MAGELLA MEDICAL ASSOCIATES OF GEORGIA, P.C.
                             MAGELLA MEDICAL ASSOCIATES MIDWEST, P.C.
                             MAGELLA MEDICAL GROUP, INC. (d/b/a MAGELLA
                              MEDICAL GROUP, A MEDICAL CORPORATION)
                             MAGELLA NEVADA, LLC
                             MAGELLA TEXAS, LLC
                             MARCIA J. PERNOLL, M.D. PROF. CORP.
                              d/b/a OBSTETRIX MEDICAL GROUP OF NEVADA, LTD.
                             MOUNTAIN STATES NEONATOLOGY, INC.
                             NEONATAL AND PEDIATRIC INTENSIVE CARE
                                  MEDICAL GROUP, INC.
                             NEONATOLOGY ASSOCIATES, P.A.
                             NEONATOLOGY-CARDIOLOGY ASSOCIATES, P.A.
                             NEWBORN SPECIALISTS, P.C.
                             OBSTETRIX MEDICAL GROUP OF COLORADO, P.C.
                             OBSTETRIX MEDICAL GROUP OF KANSAS AND
                                  MISSOURI, P.A.
                             OBSTETRIX MEDICAL GROUP OF TEXAS, P.A.
                             OZARK NEONATAL ASSOCIATES, INC.

                             By: /s/ Karl B. Wagner
                                 ----------------------------------------
                                 Karl B. Wagner, Attorney-in-Fact

                                     - 3 -
<PAGE>

                             PEDIATRIX MEDICAL GROUP OF ARKANSAS, P.A.
                             PEDIATRIX MEDICAL GROUP OF CALIFORNIA, A
                                  PROFESSIONAL CORPORATION
                             PEDIATRIX MEDICAL GROUP OF COLORADO, P.C.
                             PEDIATRIX MEDICAL GROUP OF GEORGIA, P.C.
                             PEDIATRIX MEDICAL GROUP OF INDIANA, P.C.
                             PEDIATRIX MEDICAL GROUP OF KANSAS, P.A.
                             PEDIATRIX MEDICAL GROUP OF MISSOURI, P.C.
                             PEDIATRIX MEDICAL GROUP OF OKLAHOMA, P.C.
                             PEDIATRIX MEDICAL GROUP OF PENNSYLVANIA, P.C.
                             PEDIATRIX MEDICAL GROUP OF PUERTO RICO, P.S.C.
                             PEDIATRIX MEDICAL GROUP OF TEXAS, P.A.
                             PEDIATRIX MEDICAL GROUP NEONATOLOGY AND
                                  PEDIATRIC INTENSIVE CARE SPECIALISTS
                                  OF NEW YORK, P.C.
                             PEDIATRIX MEDICAL GROUP
                             PEDIATRIX OF MARYLAND, P.A.
                             PERINATAL PEDIATRICS, P.A.
                             PERNOLL MEDICAL GROUP OF NEVADA, LTD.
                                  d/b/a PEDIATRIX MEDICAL GROUP OF NEVADA
                             SAVANNAH NEONATOLOGY, INC.
                             ST. JOSEPH NEONATOLOGY CONSULTANTS, P.A.
                             TEXAS MATERNAL FETAL MEDICINE, P.A.

                             By: /s/ Karl B. Wagner
                                 -----------------------------------------------
                                 Karl B. Wagner, Attorney-in-Fact

                             PEDIATRIX MEDICAL GROUP OF OHIO CORP.

                             By: /s/ Karl B. Wagner
                                 -----------------------------------------------
                                 Karl B. Wagner, Secretary

                                     - 4 -
<PAGE>
                             ASSOCIATES IN NEONATOLOGY, INC.
                             BNA ACQUISITION COMPANY, INC.
                             CENTRAL OKLAHOMA NEONATOLOGY
                                  ASSOCIATES, INC.
                             FLORIDA REGIONAL NEONATAL ASSOCIATES, P.A.
                             GNPA ACQUISITION COMPANY, INC.
                             MAGELLA HEALTHCARE CORPORATION
                             MNPC ACQUISITION COMPANY, INC.
                             NACF ACQUISITION COMPANY, INC.
                             NEONATAL SPECIALISTS, LTD.
                             NSPA ACQUISITION COMPANY, INC.
                             OBSTETRIX MEDICAL GROUP OF ARIZONA, P.C.
                             OBSTETRIX MEDICAL GROUP OF DELAWARE, INC.
                             OBSTETRIX MEDICAL GROUP OF PENNSYLVANIA, P.C.
                             OBSTETRIX MEDICAL GROUP OF PHOENIX, P.C.
                             OBSTETRIX MEDICAL GROUP OF
                                  WASHINGTON, INC., P.S.
                             OBSTETRIX MEDICAL GROUP, INC.
                             PALM BEACH NEO ACQUISITIONS, INC.
                             PASCV ACQUISITION COMPANY, INC.
                             PEDIATRIX MEDICAL GROUP OF DELAWARE, INC.
                             PEDIATRIX MEDICAL GROUP OF FLORIDA, INC.
                             PEDIATRIX MEDICAL GROUP OF NEW MEXICO, P.C.
                             PEDIATRIX MEDICAL GROUP OF SOUTH CAROLINA, P.A.
                             PEDIATRIX MEDICAL GROUP OF TENNESSEE, P.C.
                             PEDIATRIX MEDICAL GROUP OF WASHINGTON, INC., P.S.
                             PEDIATRIX MEDICAL GROUP, INC. (Utah)
                             PEDIATRIX MEDICAL GROUP, P.A.
                             PEDIATRIX MEDICAL GROUP, P.C. (Virginia)
                             PEDIATRIX MEDICAL GROUP, P.C. (West Virginia)
                             PMG ACQUISITION CORP.
                             PNA ACQUISITION CO., INC.
                             RPNA ACQUISITION COMPANY, INC.
                             SCPMC ACQUISITION CO.
                             SNCA ACQUISITION COMPANY, INC.

                             By: /s/ Karl B. Wagner
                                 -----------------------------------------------
                                 Karl B. Wagner, Treasurer

                                     - 5 -
<PAGE>

                             FLEET NATIONAL BANK

                             By: /s/ Carol Castle
                                 -----------------------------------------------
                                 Carol Castle, Director

                                     - 6 -
<PAGE>

                             U.S. BANK NATIONAL ASSOCIATION

                             By: /s/ Walker S. Choppin
                                 -----------------------------------------------
                                 Walker S. Choppin, Senior Vice President

                                     - 7 -
<PAGE>
                             HSBC BANK USA

                             By: /s/ Christopher Harrocks
                                 -----------------------------------------------
                                 Christopher Harrocks, Vice President

                                     - 8 -
<PAGE>
                             UBS AG, STAMFORD BRANCH

                             By: /s/ Wilfred V. Saint
                                 -----------------------------------------------
                                 Wilfred V. Saint, Associate Director
                                 Banking Products Services, US

                             By: /s/ Susan Brunner
                                 -----------------------------------------------
                                 Susan Brunner, Associate Director
                                 Banking Products Services, US

                                     - 9 -
<PAGE>
                             THE INTERNATIONAL BANK OF MIAMI, N.A.

                             By: /s/ Eduardo Hornero
                                 -----------------------------------------------
                                 Eduardo Hornero, Vice President

                             By: /s/ Jorge Maklouf
                                 -----------------------------------------------
                                 Jorge Maklouf, Senior Vice President

                                     - 10 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00042-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00042-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00042-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00042-of-00352.parquet"}]]